STOCK TITAN

Inventiva S.A. American Depository Shares - $IVA STOCK NEWS

Welcome to our dedicated page for Inventiva S.A. American Depository Shares news (Ticker: $IVA), a resource for investors and traders seeking the latest updates and insights on Inventiva S.A. American Depository Shares stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Inventiva S.A. American Depository Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Inventiva S.A. American Depository Shares's position in the market.

Rhea-AI Summary
Ligand Pharmaceuticals appoints Martine Zimmermann as independent director, bringing 25 years of global pharmaceutical industry experience. Her expertise in development and regulatory affairs will be valuable as Ligand builds its partnered programs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.31%
Tags
management
Inventiva S.A. American Depository Shares

Nasdaq:IVA

IVA Rankings

IVA Stock Data

172.50M
14.05M
9.33%
0.11%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States of America
Daix